Journal of Psychoactive Drugs

Papers
(The H4-Index of Journal of Psychoactive Drugs is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Loneliness, Mental Health, and Substance Use among US Young Adults during COVID-19201
A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy79
Chemical Composition of Traditional and Analog Ayahuasca25
Pilot Evaluation of a Residential Drug Addiction Treatment Combining Traditional Amazonian Medicine, Ayahuasca and Psychotherapy on Depression and Anxiety24
Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States23
A Complex Case of Kratom Dependence, Depression, and Chronic Pain in Opioid Use Disorder: Effects of Buprenorphine in Clinical Management23
Efficacy of Psychoactive Drugs for the Treatment of Posttraumatic Stress Disorder: A Systematic Review of MDMA, Ketamine, LSD and Psilocybin22
The Psychedelic Renaissance in Clinical Research: A Bibliometric Analysis of Three Decades of Human Studies with Psychedelics20
Use of Benefit Enhancement Strategies among 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) Users: Associations with Mystical, Challenging, and Enduring Effects19
Mystical Experiences in Retrospective Reports of First Times Using a Psychedelic in Finland18
Use of “Poppers” among Adults in the United States, 2015-201716
A Systematized Review of Drug-checking and Related Considerations for Implementation as A Harm Reduction Intervention15
The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review14
Personality Traits in Former Spanish Substance Users Recovered with Ayahuasca14
Long-term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-containing Mushrooms14
0.029052972793579